These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20606841)

  • 1. Quinpristin-Dalfopristin resistance among methicillin-resistant strains of staphylococci.
    Bhatawadekar S; Chattopadhyay A
    Indian J Pharmacol; 2010 Feb; 42(1):56. PubMed ID: 20606841
    [No Abstract]   [Full Text] [Related]  

  • 2. Susceptibility of clinical methicillin-resistant Staphylococci isolates to new antibiotics.
    Oksuz L; Gurler N
    J Infect Dev Ctries; 2013 Nov; 7(11):825-31. PubMed ID: 24240040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future management of infections due to methicillin-resistant staphylococci infections: the role of quinupristin/dalfopristin.
    Péchère JC
    J Antimicrob Chemother; 1999 Sep; 44 Suppl A():11-8. PubMed ID: 10511392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of quinupristin/dalfopristin in comparison with five antibiotics against worldwide clinical isolates of staphylococci.
    Auckenthaler R; Courvalin P; Féger C; Roche G;
    Clin Microbiol Infect; 2000 Nov; 6(11):608-12. PubMed ID: 11168064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci.
    Tünger A; Aydemir S; Uluer S; Cilli F
    Indian J Med Res; 2004 Dec; 120(6):546-52. PubMed ID: 15654141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998.
    Santos Sanches I; Mato R; de Lencastre H; Tomasz A;
    Microb Drug Resist; 2000; 6(3):199-211. PubMed ID: 11144420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase-negative staphylococci strains: a systematic review and meta-analysis.
    Shariati A; Dadashi M; Chegini Z; van Belkum A; Mirzaii M; Khoramrooz SS; Darban-Sarokhalil D
    Antimicrob Resist Infect Control; 2020 Apr; 9(1):56. PubMed ID: 32321574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methicillin-resistant staphylococci.
    Chambers HF
    Clin Microbiol Rev; 1988 Apr; 1(2):173-86. PubMed ID: 3069195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methicillin Resistant Staphylococci: Prevalence and susceptibility patterns in a burn center in Ahvaz from 2013-2014.
    Ekrami A; Abbasi Montazeri E; Kaydani GA; Shokoohizadeh L
    Iran J Microbiol; 2015 Aug; 7(4):208-13. PubMed ID: 26697160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibilities of healthcare- and community-associated methicillin-resistant staphylococci to the novel des-F(6)-quinolone DX-619.
    Watanabe S; Ito T; Hiramatsu K
    J Antimicrob Chemother; 2007 Dec; 60(6):1384-7. PubMed ID: 17890283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHARACTERISTICS OF METHICILLIN-RESISTANT STAPHYLOCOCCI.
    SUTHERLAND R; ROLINSON GN
    J Bacteriol; 1964 Apr; 87(4):887-99. PubMed ID: 14137628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci.
    von Eiff C; Peters G
    J Antimicrob Chemother; 1999 Apr; 43(4):569-73. PubMed ID: 10350389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of quinupristin/dalfopristin against gram-positive bacteria: clinical applications and therapeutic potential.
    Rubinstein E; Bompart F
    J Antimicrob Chemother; 1997 May; 39 Suppl A():139-43. PubMed ID: 9511078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS; Watters AA; Fritsche TR; Jones RN
    BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinupristin-dalfopristin.
    Bryson HM; Spencer CM
    Drugs; 1996 Sep; 52(3):406-15. PubMed ID: 8875130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the global SMART (GSMART) surveillance study.
    Sader HS; Jones RN; Ballow CH; Biedenbach DJ; Cered RF;
    Braz J Infect Dis; 2001 Feb; 5(1):21-31. PubMed ID: 11290311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methicillin resistance and biofilm production in clinical isolates of Staphylococcus aureus and coagulase-negative Staphylococcus in México.
    García A; Martínez C; Juárez RI; Téllez R; Paredes MA; Herrera MDR; Giono S
    Biomedica; 2019 Sep; 39(3):513-523. PubMed ID: 31584765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinupristin-dalfopristin resistance among gram-positive bacteria in Taiwan.
    Luh KT; Hsueh PR; Teng LJ; Pan HJ; Chen YC; Lu JJ; Wu JJ; Ho SW
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3374-80. PubMed ID: 11083643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Susceptibility of methicillin-sensitive and methicillin-resistant staphylococci to ciprofloxacin].
    Namysł E; Piechowicz L; Krzywińska E; Galiński J
    Med Dosw Mikrobiol; 1993; 45(2):149-52. PubMed ID: 8309287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.
    Bogdanovich T; Esel D; Kelly LM; Bozdogan B; Credito K; Lin G; Smith K; Ednie LM; Hoellman DB; Appelbaum PC
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3325-33. PubMed ID: 16048943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.